Metabolic control in recipients of duct-occluded segmental pancreatic grafts: a four-year follow-up.
Holdaas
H
H
Department of Medicine, National Hospital, Oslo, Norway.
Brekke
I B
IB
Hartmann
A
A
Fauchald
P
P
Berg
K J
KJ
Sødal
G
G
Jervell
J
J
Flatmark
A
A
D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery; D005500:Follow-Up Studies; D005934:Glucagon; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000032:analysis; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D016035:Pancreas Transplantation / Q000502:physiology*; D010183:Pancreatic Ducts; D011183:Postoperative Complications
D001786:Blood Glucose; D002096:C-Peptide; D005934:Glucagon; D006442:Glycated Hemoglobin